Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The E7 protein of human papillomavirus type 6 (HPV6) is a small oncoprotein that plays a crucial role in the viral life cycle. It primarily functions by disrupting the retinoblastoma protein (pRb)-E2F interaction, leading to the activation of E2F transcription factors and subsequent cell cycle progression. Unlike high-risk HPV E7 proteins, HPV6 E7 has lower oncogenic potential and is primarily associated with benign lesions such as genital warts. It is essential for efficient viral genome maintenance within infected cells. Detection of E7 antibodies or mRNA can serve as a biomarker for HPV6 infection.
Disruption of pRb-E2F complex, leading to uncontrolled cell cycle progression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E7 Protein of Human Papillomavirus Type 6 (HPV6 E7).